Clinical trial
Phase II Study of Digitoxin to Treat Cystic Fibrosis
NCT00782288 is registered in ClinicalTrials.gov with National Jewish Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase II Study of Digitoxin to Treat Cystic Fibrosis
- Lead sponsor
- National Jewish Health
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- August 31, 2010
- Completion date
- August 31, 2016
- Enrollment
- 24 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.